Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements

The prostate-specific antigen (PSA) assays currently employed for the detection of prostate cancer (PCa) lack the specificity needed to differentiate PCa from benign prostatic hyperplasia and have high false positive rates. The PSA calibrants used to create calibration curves in these assays are typ...

Descripción completa

Detalles Bibliográficos
Autor principal: McJimpsey, Erica L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766849/
https://www.ncbi.nlm.nih.gov/pubmed/26911983
http://dx.doi.org/10.1038/srep22050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766849/
https://www.ncbi.nlm.nih.gov/pubmed/26911983
http://dx.doi.org/10.1038/srep22050

Ejemplares similares